LeonaBio (LONA) Stock Forecast: StockMap's 2-Week Call
LONA stock forecast: StockMap's model calls LeonaBio Strong Underperform for the two weeks after the Nov 19 close: it expects LONA to trail the growth index. It is a call on the gap, not a price target. Right in 5 of 6 two-week windows on LONA since Aug 21; by chance, a call on the same dates was right 59% of the time.
LeonaBio last closed at $2.46, -7.17% on the session.
Against the IVW growth benchmark the position is -4.84% over the forecast window.
LeonaBio's market cap is $32.17M as of November 19, 2026.
Calls down ↘: the model's call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -51 (behind).
Where LONA sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 1 bullish and 14 bearish.
Agreement across those insights is 93%.
49 daily calls for LONA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks LeonaBio in the 2nd percentile on return on equity, where 100 is best.
LeonaBio is classified under Health Care / Pharmaceuticals.
StockMap tracks LeonaBio as the 116th largest of the 153 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.
Across that group the current two-week reads are 80 Moderate Underperform, 44 Neutral and 29 Strong Underperform.
On that composite LeonaBio ranks 128th of 153 in the group, against a group median of -0.36.